Gallagher Carol Giltner — SEC insider filings

SEC reporting owner CIK 1329959. 20 insider filings on record with FilingPulse; latest filed 2026-10-08.

Transaction summary — filings shown

Covers all 20 filings on record, filed 2021-06-04 to 2026-10-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Atara Biotherapeutics, Inc. (ATRA)Director62 legs · 270,000 sh · $68,214—8
PMV Pharmaceuticals, Inc. (PMVP)Director5——15
Mirati Therapeutics, Inc. (MRTX)Director3——6
Turning Point Therapeutics, Inc. (TPTX)Director2——4
Certara, Inc. (CERT)Director1——1
Frazier Lifesciences Acquisition Corp (FLAC)Director1——1
TRex Bio, Inc. (TRXB)Director2——1

Insider filings — Gallagher Carol Giltner

FiledFormIssuerReported transactionsSource
2026-10-083TRex Bio, Inc. (TRXB)Holdings only — no transactions reportedEDGAR
2026-10-084TRex Bio, Inc. (TRXB)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2026-06-054PMV Pharmaceuticals, Inc. (PMVP)Grant/award (A): 42,000 (derivative) @ $0 · Gift (G): 42,000 (derivative) @ $0 · Gift (G): 42,000 (derivative) @ $0EDGAR
2025-06-124Atara Biotherapeutics, Inc. (ATRA)Grant/award (A): 7,828 @ $0EDGAR
2025-06-094PMV Pharmaceuticals, Inc. (PMVP)Grant/award (A): 33,500 (derivative) @ $0 · Gift (G): 33,500 (derivative) @ $0 · Gift (G): 33,500 (derivative) @ $0EDGAR
2024-06-104PMV Pharmaceuticals, Inc. (PMVP)Grant/award (A): 67,500 (derivative) @ $0 · Gift (G): 67,500 (derivative) @ $0 · Gift (G): 67,500 (derivative) @ $0EDGAR
2024-04-024Atara Biotherapeutics, Inc. (ATRA)Grant/award (A): 150,000 @ $0EDGAR
2024-01-234Mirati Therapeutics, Inc. (MRTX)Disposition to issuer (D): 7,555 · Disposition to issuer (D): 6,808 · Disposition to issuer (D): 12,784 (derivative)EDGAR
2024-01-034Mirati Therapeutics, Inc. (MRTX)Grant/award (A): 6,808 @ $58.75EDGAR
2023-11-154Atara Biotherapeutics, Inc. (ATRA)Purchase (P): 179,020 @ $0.22 · Purchase (P): 90,980 @ $0.31EDGAR
2023-06-234Mirati Therapeutics, Inc. (MRTX)Grant/award (A): 7,555 @ $0 · Grant/award (A): 12,784 (derivative) @ $0EDGAR
2023-06-124PMV Pharmaceuticals, Inc. (PMVP)Grant/award (A): 21,500 (derivative) @ $0 · Gift (G): 21,500 (derivative) @ $0 · Gift (G): 21,500 (derivative) @ $0EDGAR
2023-06-024Atara Biotherapeutics, Inc. (ATRA)Grant/award (A): 57,000 @ $0 · Grant/award (A): 79,500 (derivative) @ $0EDGAR
2022-11-234Frazier Lifesciences Acquisition Corp (FLAC)Option exercise (M): 30,000 (derivative)EDGAR
2022-11-084PMV Pharmaceuticals, Inc. (PMVP)Grant/award (A): 39,000 (derivative) @ $0 · Gift (G): 39,000 (derivative) @ $0 · Gift (G): 39,000 (derivative) @ $0EDGAR
2022-08-174Turning Point Therapeutics, Inc. (TPTX)Disposition to issuer (D): 8,500 (derivative) · Disposition to issuer (D): 8,500 (derivative) · Disposition to issuer (D): 30,000 (derivative)EDGAR
2022-06-274Atara Biotherapeutics, Inc. (ATRA)Grant/award (A): 20,500 @ $0 · Grant/award (A): 31,500 (derivative) @ $0EDGAR
2021-06-164Certara, Inc. (CERT)Grant/award (A): 7,059 @ $0EDGAR
2021-06-094Atara Biotherapeutics, Inc. (ATRA)Grant/award (A): 11,000 @ $0 · Grant/award (A): 17,500 (derivative) @ $0EDGAR
2021-06-044Turning Point Therapeutics, Inc. (TPTX)Grant/award (A): 8,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-06-03 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1329959 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs